Sentences with phrase «clinical and translational research program»

He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma.

«The CTR - IN is providing unique opportunities for junior faculty at our partner institutions to develop their clinical and translational research programs to the level of national competitiveness,» said Carl Reiber, UNLV senior vice provost, who was instrumental in the development of the program.

Not exact matches

CTI - 1601 was invented by R. Mark Payne, MD, professor of Pediatric Cardiology at Indiana University School of Medicine and director of the Translational Research Training Program of Indiana Clinical Translational Sciences Institute.

D. degrees train individuals in clinical and basic research, but translational research programs strive to integrate these two sides of medical science by connecting people and building networks.

NIH launched the CTSA program in 2006 to fund clinical and translational research hubs at institutions around the country, which are individually known as CTSAs.

TL1s are aimed at graduate students and postdocs from Ph.D. or combined - degree programs who are looking to pursue clinical and translational research careers.

These training programs share features such as courses, seminars, and workshops focused on clinical and translational issues; access to specialized equipment and databases; mentorship from established clinical and translation scientists; and pilot funding for research projects.

The National Institutes of Health's (NIH's) Roadmap for Medical Research acknowledges the importance of behavioral and social science research, and the agency's Clinical and Translational Science Awards require a behavioral science component in the programs of awardee instiResearch acknowledges the importance of behavioral and social science research, and the agency's Clinical and Translational Science Awards require a behavioral science component in the programs of awardee instiresearch, and the agency's Clinical and Translational Science Awards require a behavioral science component in the programs of awardee institutions.

The study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23 HD054720), Flora Family Foundation, UCSF Catalyst Award, UCSF Resource Allocation Program, Brain & Behavior Research Foundation Young Investigator Award, Stanford University Lucile Packard Foundation for Children's Health, Spectrum Child Health & Clinical and Translational Science Award and the Extraordinary Brain Series of the Dyslexia Foundation.

The SHOW project is supported by grants from the Wisconsin Partnership Program, the National Institutes of Health (IRC2HL101468 - 01), and the UW Institute for Clinical and Translational Research (KL2 - RR025012).

«Activation of these cell receptors appear to prevent brain cells from cleaning out the trash — the toxic buildup of proteins, such as alpha - synuclein, tau and amyloid, common in neurodegenerative diseases,» says the study's senior author, neurologist Charbel Moussa, MBBS, PhD, director of Georgetown's Laboratory for Dementia and Parkinsonism, and scientific and clinical research director of the GUMC Translational Neurotherapeutics Program.

The Clinical and Translational Science Awards (CTSAs) are large grants (from about $ 4 million to $ 23 million a year) for training programs, regulatory staff, and other support for bench - to - bedside research at academic medical centers.

William Crowley, director of clinical research for Massachusetts General Hospital in Boston, observes that, although NIH's many programs to support training in clinical and translational research have been «spectacular,» the academy is now filled with well - trained translational researchers, all trying to land independent research grants just as the NIH pay line is plummeting.

«They should follow their own basic interests, whether in biochemistry, microbiology, or training as a physicist, but really think about getting extra training through a degree - granting program in clinical and translational research because this is going to position them to be more forward thinking,» says NCRR's Alving.

«I like to call it intelligent crossover training,» says Karina Davidson, associate director of the Irving Institute for Clinical and Translational Research, Columbia's CTSA program.

M. D. Feldman, L. Huang, B. J. Guglielmo, R. Jordan, J. Kahn, J. M. Creasman, J. P. Wiener - Kronish, K. A. Lee, A. Tehrani, K. Yaffe, and J. S. Brown, «Training the next generation of research mentors: The University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program.»

«RNAi therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.»

As VRC Director, Dr. Mascola provides scientific leadership to the basic, clinical, and translational research activities of the VRC; develops vaccine research programs to meet public health needs; allocates VRC resources; and develops policies for the execution of multi-disciplinary research.

This work was supported by National Institutes of Health (NIH) grants K23 DK081604, P30 DK036836, and the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the Fundación Alfonso Martín Escudero; and the Clinical Translational Science Award UL1RR025758 to Harvard University and BIDMC from the National Center for Research Resources (NCRR).

About the Anna - Maria Kellen Clinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innClinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innClinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innclinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innResearch Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innclinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innovation.

The SUCCESS Center (Support Center for Clinical & Translational Science) is the consolidated entry point for SCTR (South Carolina Clinical and Translational Research) Institute programs, research support services and research navigation Research) Institute programs, research support services and research navigation research support services and research navigation research navigation support.

Our cutting - edge laboratory, clinical, and translational research programs are advancing the frontiers of surgical care.

To establish and conduct the highest quality collaborative translational and clinical research program investigating risk assessment, risk reduction interventions, cancer risk and early detection markers, and cancer screening

The program combines basic, translational and clinical research related to the top - clinical functions of neonatal intensive care (NICU) and obstetric high care (OHC), which together form the perinatal center of the MUMC +.

«The program will also form an excellent national meeting place for preclinical and clinical researchers in the WCMM and SciLifeLab programs with the ultimate goal of realizing Swedish translational research from molecule to man.»

I am also the director of the Center for the Study and Treatment of Fear and Anxiety and the PI / director of the Hispanic Clinical and Translational Research Education and Career Development Program.

This research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of Research Center between Emory University, Georgia Tech and the University of Georgia.

Seed Money for Translational Pilot Projects Charis Eng, MD, PhD, Chair, Genomic Medicine Institute, advises all faculty that the Cleveland Clinical and Translational Sciences Collaborative (CTSC) and the School of Medicine, Case Western Reserve University, will provide seed money to faculty in multidisciplinary programs for Pilot Projects that will lead to effi cient use of resources and support of inter-institutional, clinical translational research in the City Translational Pilot Projects Charis Eng, MD, PhD, Chair, Genomic Medicine Institute, advises all faculty that the Cleveland Clinical and Translational Sciences Collaborative (CTSC) and the School of Medicine, Case Western Reserve University, will provide seed money to faculty in multidisciplinary programs for Pilot Projects that will lead to effi cient use of resources and support of inter-institutional, clinical translational research in the City of ClClinical and Translational Sciences Collaborative (CTSC) and the School of Medicine, Case Western Reserve University, will provide seed money to faculty in multidisciplinary programs for Pilot Projects that will lead to effi cient use of resources and support of inter-institutional, clinical translational research in the City Translational Sciences Collaborative (CTSC) and the School of Medicine, Case Western Reserve University, will provide seed money to faculty in multidisciplinary programs for Pilot Projects that will lead to effi cient use of resources and support of inter-institutional, clinical translational research in the City of Clclinical translational research in the City translational research in the City of Cleveland.

Dr. Peel leads a 36 - member department executing clinical, translational, and applied research programs and clinical diagnostic services which directly impact and benefit Service Members and DoD beneficiaries, as well as the world community.

The IACS and CCCT Moon Shot ™ platforms will continue to provide drug development and translational research as the Navire programs advance towards clinical testing.

This training program will consist of 14 months of clinical training at Northwell Health hospitals and ambulatory cancer center in Lake Success, NY, followed by two years of post-doctoral translational research training at Cold Spring Harbor Laboratory.

Home / Research / Fellows Programs / CSHL and Hofstra Northwell Health Clinical and Translational Fellowship

The program has a strong emphasis on breast epithelial cell and molecular biology, basic science driven translational and clinical research, and molecular epidemiology.

Your financial support will help us fund important research programs so that we can move our basic discoveries more rapidly from the proof - of - principle stage through translational research and preclinical testing that leads to human clinical trials.

Administered semi-annually, this program supports clinical and translational research in child health under four categories:

Rudick, who is co-principal investigator of Cleveland Clinic's CTSA program, says the CTSA movement will increase clinical and translational research capacity by drawing in researchers who have not been previously involved in clinical research and by exposing students to clinical research at an earlier stage in their careers.

Ensure our signature programs» national reputation based upon translational clinical research, so that patients from a broad geographic area will seek out UConn Health for prevention, diagnosis, and treatment.

Dr. Georgia L. Wiesner is an Ingram Professor of Cancer Research, Professor of Medicine in the Division of Genetic Medicine and the Director of the new Clinical and Translational Hereditary Cancer Program for the Vanderbilt - Ingram Cancer Center.

Penn Medicine's Pancreatic Cancer Research Center is a leading edge, translational research program that combines basic science research and clinical investResearch Center is a leading edge, translational research program that combines basic science research and clinical investresearch program that combines basic science research and clinical investresearch and clinical investigation.

* Specialty and primary care clinical programs * Clinical, basic and translational research * Education for healthcare professionals and patients * Clinical data maclinical programs * Clinical, basic and translational research * Education for healthcare professionals and patients * Clinical data maClinical, basic and translational research * Education for healthcare professionals and patients * Clinical data maClinical data management

Recently, iBET became the coordinator of a research unit funded by FCT, iNOVA4Health, a translational medicine program organising the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals «pre-discovery», technological scientists involved in «preclinical development», and clinicians involved in «early clinical and first in man clinical trials» from institutions within NOVA University of Lisbon.

These programs build research capacity in states that historically have had low levels of NIH funding by supporting basic, clinical, and translational research; faculty development; and infrastructure improvements.

The Clinical and Translational Science Award (CTSA) program, part of the NIH's National Center for Advancing Translational Sciences (NCATS), supports a national consortium of more than 60 medical research institutions in 31 states.

In this role, she provides strategic leadership to the clinical development and translational research programs, and will oversee Medical Affairs, Global Clinical Development groups, Clinical Operations and Drug Safety / Pharmacoviclinical development and translational research programs, and will oversee Medical Affairs, Global Clinical Development groups, Clinical Operations and Drug Safety / PharmacoviClinical Development groups, Clinical Operations and Drug Safety / PharmacoviClinical Operations and Drug Safety / Pharmacovigilance.

She is the Principle Investigator of the I - SPY TRIAL program, a multi-site neoadjuvant clinical trial (which includes phase 2 and 3 trials) that has evolved into a model for translational research and innovation in clinical trial design.

It was funded by the Consortium for Frontotemporal Dementia Research, Bluefield Project to Cure FTD, National Institutes of Health, UCSF Resource Allocation Program, UCSF Alzheimer's Disease Research Center, Chartrand Foundation and Clinical & Science Translational Institute, Howard Hughes Medical Institute, Alzheimer's Association, Welch Foundation, and Alzheimer's Drug Discovery Foundation.

This research was supported by the Vanderbilt Office of Clinical and Translational Scientist Development, the Vanderbilt Clinical and Translational Research Scholars Program and the National Institute on Aging of the National Institutes of Health (grant numbers AG046379 and AGresearch was supported by the Vanderbilt Office of Clinical and Translational Scientist Development, the Vanderbilt Clinical and Translational Research Scholars Program and the National Institute on Aging of the National Institutes of Health (grant numbers AG046379 and AGResearch Scholars Program and the National Institute on Aging of the National Institutes of Health (grant numbers AG046379 and AG045735).

This work was supported by National Institutes of Health (NIH) R01 HL109706 and Colorado Clinical and Translational Sciences Institute Grant UL1 TR000154 from NIH / National Center for Advancing Translational Sciences and Howard Hughes Medical Institute in collaboration with the Biological Sciences Initiative and Undergraduate Research Opportunities Program at the University of Colorado, Boulder, CO..

Two shared resources provide support for the program; the Blue Buffalo Clinical Trials Office / Biospecimen Repository, also known as the Veterinary Clinical Research Support Shared Resource (VCRSSR, supported by the OSU Comprehensive Cancer Center and Center for Clinical and Translational Sciences) and the Comparative Pathology and Mouse Phenotyping Shared Resource (CPMPSR).

Collaborative research is a major component of the Signature Program that drives the identification and validation of new targets for therapy, ultimately providing enhanced opportunities for translational clinical trials.